Andrej Savol, PhD is a computational biologist specializing in precision oncology and next generation sequencing data analysis. In industrial contexts his focus has been development of novel biomarkers and diagnostic methods that aid clinicians in treatment selection. He is currently a strategic team leader at Foundation Medicine, Inc., a precision diagnostics and informatics company.
He completed his PhD in Computational Biology at the University of Pittsburgh and worked for several years at Massachusetts General Hospital in their Molecular Biology Department. His research interests span the multiomics space and have drawn on close collaborations with researchers leveraging RNA-seq, DNA-seq, ChIP-seq, and ATAC-seq data in search of better diagnostic solutions and richer understanding of cellular behavior.